Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

VKTX

Viking Therapeutics Inc

Sep 12 • 04:00PM ET

24.81

-0.93 -3.61 %

Healthcare • Biotechnology • USA • NASD

Peers: MDGL AKRO GLMD AKBA ATON ARDX BOLD TVRD EYPT FGEN

| Held by: VTI VB XBI VBK VXF SCHA VHT IWR IWD LABU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.53	Insider Own	2.98%	Shs Outstand	112.33M	Perf Week	-8.04%
Market Cap	2.79B	Forward P/E	-	EPS next Y	-3.13	Insider Trans	-1.01%	Shs Float	109.09M	Perf Month	-39.88%
Enterprise Value	1.98B	PEG	-	EPS next Q	-0.70	Inst Own	68.16%	Short Float	24.45%	Perf Quarter	-13.19%
Income	-171.55M	P/S	-	EPS this Y	-148.19%	Inst Trans	-1.77%	Short Ratio	4.48	Perf Half Y	-16.55%
Sales	0.00M	P/B	3.50	EPS next Y	-24.77%	ROA	-19.33%	Short Interest	26.68M	Perf YTD	-38.34%
Book/sh	7.08	P/C	3.45	EPS next 5Y	-	ROE	-19.99%	52W High	81.73 -69.64%	Perf Year	-54.60%
Cash/sh	7.18	P/FCF	-	EPS past 3/5Y	-12.29% -23.00%	ROIC	-21.55%	52W Low	18.92 31.13%	Perf 3Y	685.13%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.14% 5.61%	Perf 5Y	305.39%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-63.73%	Oper. Margin	-	ATR (14)	1.86	Perf 10Y	281.11%
Dividend Ex-Date	-	Quick Ratio	25.86	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	36.60	Recom	1.12
Dividend Gr. 3/5Y	- -	Current Ratio	25.86	EPS Q/Q	-190.03%	SMA20	-10.10%	Beta	0.65	Target Price	93.93
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-20.07%	Rel Volume	0.67	Prev Close	25.74
Employees	36	LT Debt/Eq	0.00	Earnings	Jul 23 AMC	SMA200	-21.99%	Avg Volume	5.95M	Price	24.81
IPO	Apr 29, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-29.90% -	Trades		Volume	4,011,852	Change	-3.61%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight	$104
Apr-08-25	Initiated	Goldman	Neutral	$30
Feb-13-25	Initiated	Scotiabank	Sector Outperform	$102
Feb-07-25	Initiated	Citigroup	Neutral	$38
Dec-02-24	Initiated	Piper Sandler	Overweight
Nov-22-24	Initiated	B. Riley Securities	Buy	$109
Nov-04-24	Reiterated	H.C. Wainwright	Buy	$90 → $102
Sep-11-24	Initiated	JP Morgan	Overweight	$80
Jun-27-24	Initiated	Morgan Stanley	Overweight	$105
May-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$115 → $116
Mar-26-24	Reiterated	Oppenheimer	Outperform	$116 → $138
Mar-07-24	Initiated	Jefferies	Buy	$110
Feb-28-24	Reiterated	Oppenheimer	Outperform	$46 → $116
May-31-23	Resumed	ROTH MKM	Buy	$32
Mar-28-23	Reiterated	Maxim Group	Buy	$15 → $25
Mar-17-23	Initiated	Stifel	Buy	$22
Jul-29-21	Resumed	BTIG Research	Buy	$20
May-25-21	Downgrade	Raymond James	Strong Buy → Outperform	$27 → $12
Jun-05-20	Initiated	BMO Capital Markets	Outperform	$14
May-05-20	Initiated	Chardan Capital Markets	Buy	$15

Show Previous Ratings

Sep-11-25 03:43PM	Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback (Motley Fool)
10:02AM	Where Does VKTX Stock Stand After the Obesity Pill Setback? (Zacks)
Sep-10-25 10:28AM	Is NVO's Major Restructuring Plan an Indication to Sell the Stock? (Zacks)
Sep-09-25 09:30AM	Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy? (Zacks)
Sep-08-25 07:33PM	Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.56%
11:58AM	Loading…
11:58AM	Jim Cramer Recommends Eli Lilly Over Viking Therapeutics (Insider Monkey)
Sep-07-25 11:14AM	Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time. (Motley Fool)
Sep-05-25 04:10AM	Down 34%, Should You Buy the Dip on Viking Therapeutics? (Motley Fool)
Sep-04-25 09:00AM	Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years (Motley Fool)
Sep-03-25 01:48PM	The Problem With Weight Loss Stocks (Motley Fool)
Sep-02-25 10:30AM	Viking Therapeutics Loses 20% in a Month: How to Play the Stock (Zacks)
Sep-01-25 10:54AM	NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction? (Zacks)
Aug-29-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
04:26AM	2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts (Motley Fool)
Aug-28-25 06:42PM	Why Viking Therapeutics Stock Popped Nearly 4% Today (Motley Fool)
04:30PM	Loading…
04:30PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Aug-27-25 10:52AM	Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock is a Safer Bet? (Zacks)
10:00AM	Billionaire Stanley Druckenmiller Just Bought the Dip on This Beaten-Down GLP-1 Stock (Hint: It's Not Eli Lilly or Novo Nordisk) (Motley Fool)
08:11AM	Does Lilly's New Obesity Pill Data Put It Back in the Weight Game? (Zacks)
Aug-26-25 04:08PM	Eli Lilly's 'Surprising Development' In Obesity Just Slammed Novo Stock (Investor's Business Daily)
11:09AM	Can Novo Nordisk Offset GLP-1 Pressures With Rare Disease Wins? (Zacks)
09:47AM	Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump (Investor's Business Daily)
06:15AM	Viking Therapeutics: What's Next? (Motley Fool)
Aug-24-25 08:45AM	2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts (Motley Fool)
Aug-23-25 05:00AM	Investing.coms stocks of the week (Investing.com)
Aug-22-25 11:30AM	Viking Therapeutics (VKTX) Down 23.4% Since Last Earnings Report: Can It Rebound? (Zacks)
10:21AM	Here's Why Shares in Viking Therapeutics Crashed This Week (Motley Fool)
08:49AM	Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans? (Zacks)
Aug-21-25 12:53PM	Viking Therapeutics (VKTX) Rebounds on Bargain-Hunting. Are You Missing Out? (Insider Monkey)
12:05PM	Post Obesity Pill Results Reveal: Buy, Sell or Hold VKTX Stock? (Zacks)
07:39AM	Loading…
07:39AM	Healthcare Stocks Are the Cheapest They've Been in 30 Years-and a Turnaround May Have Already Started (Barrons.com)
05:24AM	Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip? (Motley Fool)
Aug-20-25 12:59PM	Here's Why Viking Therapeutics Bounced Back Today (Motley Fool) +5.46%
11:56AM	Viking Therapeutics (VKTX) Slashes 42% on Huge Clinical Study Dropout Rate (Insider Monkey)
11:41AM	Viking Therapeutics' Stock Tanks on Mixed Data From Obesity Pill Study (Zacks)
09:30AM	Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It? (Zacks)
06:57AM	Tech selloff spreads gloom over global markets: Yahoo Finance (Yahoo Finance Video)
06:06AM	S&P Futures Tick Lower Ahead of FOMC Meeting Minutes and More Retail Earnings (Barchart)
Aug-19-25 07:22PM	Mizuho's Jared Holz talks Viking Therapeutics' massive stock drop on obesity pill data (CNBC TV) -42.12%
04:33PM	These Stocks Moved the Most Today: Intel, Home Depot, Palo Alto, Viking Therapeutics, Palantir, Medtronic, and More (Barrons.com)
03:56PM	Viking Therapeutics stock plunges: Weight-loss pill trial disappoints (Yahoo Finance Video)
02:59PM	These Stocks Are Moving the Most Today: Intel, Home Depot, Palo Alto, Viking Therapeutics, Palantir, Medtronic, and More (Barrons.com)
02:21PM	The market reaction is overdone on Viking Therapeutics, says BTIG's Justin Zelin (CNBC TV)
01:21PM	Viking Therapeutics plummets on new obesity drug data. Here's a breakdown (CNBC TV)
12:46PM	Viking Therapeutics Stock Plunges as Oral Obesity Drug Shows Higher Dropout Rates (GuruFocus.com)
11:49AM	Top Stock Movers Now: Intel, Palo Alto Networks, Nvidia, and More (Investopedia)
11:24AM	Why Novo Nordisk Stock Popped Today (Motley Fool)
11:23AM	Viking Therapeutics Stock Plunges on Oral Weight-Loss Pill Study Results (Investopedia)
11:21AM	Stock Market Today: Home Depot, Intel, and Viking Therapeutics are on the move (TheStreet)
11:16AM	Why Viking Therapeutics Stock Crashed Today (Motley Fool)
10:57AM	Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate (Yahoo Finance)
10:40AM	Palo Alto, Viking Holdings, Viking Therapeutics: Trending Tickers (Yahoo Finance Video)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
10:17AM	This Weight-Loss Stock Is Down 40%. It Lowers the Risks for Eli Lilly and Novo Nordisk. (Barrons.com)
10:17AM	This Weight-Loss Stock Fell 40%. It Lowers the Risks for Eli Lilly and Novo Nordisk. (Barrons.com)
09:35AM	Viking Therapeutics Slumps as Weight-Loss Pill Underwhelms (Bloomberg)
09:11AM	Viking Therapeutics' stock tumbles after results of oral weight-loss drug trial. It has company. (MarketWatch)
09:04AM	Viking Therapeutics Crashes 35% On Mixed Results For Its Weight-Loss Pill (Investor's Business Daily)
08:59AM	Novo Nordisk, Eli Lilly rise after Viking obesity trial data (Investing.com)
08:31AM	This Weight-Loss Stock Fell More Than 30%. What Sent It Crashing. (Barrons.com)
08:29AM	Viking Therapeutics stock falls 37% on high dropout rate in obesity trial (Investing.com)
07:08AM	Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity (PR Newswire)
Aug-18-25 11:43PM	Viking Therapeutics Rises as Phase 3 Trials and Oral Formulation Progress Accelerate (Insider Monkey) +5.15%
06:18PM	Why Viking Therapeutics Stock Zoomed 5% Higher Today (Motley Fool)
11:45AM	NVO Stock Up on FDA Nod for Wegovy in MASH: More Upside Ahead? (Zacks)
09:13AM	Lilly Stock Down 5% This Month: Should You Buy the Dip? (Zacks)
Aug-17-25 08:55AM	1 Beaten-Down Stock That Could Soar by the End of the Year (Motley Fool)
Aug-16-25 08:45AM	Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet. (Motley Fool)
Aug-15-25 09:06AM	Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave? (Zacks)
Aug-13-25 02:30PM	Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst (Benzinga)
10:47AM	Novo Nordisk Rises 6% So Far in August: How to Play the Stock (Zacks)
04:10AM	The 3 Things That Matter for Viking Therapeutics Now (Motley Fool)
Aug-12-25 10:26AM	If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today (Motley Fool)
Aug-11-25 08:21PM	Viking Therapeutics Concludes Broad Manufacturing Agreement With CordenPharma To Support Commercialization of VK2735 (Insider Monkey)
10:23AM	Can Eli Lilly Keep Up as NVO Eyes First Oral Obesity Pill Approval? (Zacks)
Aug-08-25 05:30AM	Why a Weight-Loss Pill Is Still a Big Deal (The Wall Street Journal) +6.55%
Aug-07-25 04:20PM	Eli Lilly Dives 14% On A Shocking Obesity Setback, Sending Its Rivals Flying (Investor's Business Daily) +11.54%
11:32AM	LLY Stock Sinks Despite Q2 Earnings Beat as Obesity Pill Disappoints (Zacks)
09:55AM	Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors (Benzinga)
09:01AM	Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge. (Investor's Business Daily)
Aug-06-25 04:28PM	Is It Time to Buy Biotech Stocks? (Motley Fool) -6.32%
Aug-04-25 11:49AM	Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock? (Zacks)
09:30AM	Viking Therapeutics (VKTX) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
08:37AM	Should You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings? (Zacks)
07:15AM	This Biotech Stock Could Soar on Upcoming Clinical Data (Motley Fool)
Aug-03-25 12:32PM	2 Beaten-Down Stocks With Incredible Upside Potential (Motley Fool)
06:00AM	2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts (Motley Fool)
Aug-01-25 07:00PM	Is Viking Therapeutics the Next Big Biotech Bet? (Motley Fool)
Jul-31-25 11:37AM	Viking Therapeutics, Inc. (VKTX) Nears Obesity Drug Breakthrough with Phase 3 VK2735 Trial (Insider Monkey)
Jul-30-25 09:57AM	NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead? (Zacks)
07:30AM	2 Growth Stocks Wall Street Predicts Will Soar 74% to 159% (Barchart)
Jul-24-25 10:45AM	VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales (Zacks)
09:48AM	Viking Therapeutics, Inc. (VKTX): A Bull Case Theory (Insider Monkey)
08:48AM	This Weight-Loss Stock Sank After Earnings. It's Still a Risk for Eli Lilly, Novo Nordisk. (Barrons.com)
03:14AM	Viking Therapeutics Inc (VKTX) Q2 2025 Earnings Call Highlights: Navigating Increased R&D ... (GuruFocus.com)
Jul-23-25 04:05PM	Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update (PR Newswire)
Jul-22-25 07:15AM	Better Growth Buy: Eli Lilly vs. Viking Therapeutics (Motley Fool)
Jul-21-25 09:38AM	Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect (Zacks)
12:07AM	3 Monster Stocks in the Making to Buy Right Now (Motley Fool)
Jul-20-25 04:48AM	These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy? (Motley Fool)

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lian Brian	President & CEO	Jul 03 '25	Sale	27.80	26,889	747,633	2,388,014	Jul 03 03:31 PM
ZANTE GREG	Chief Financial Officer	Jul 03 '25	Sale	27.76	4,266	118,428	168,660	Jul 03 03:31 PM
Mancini Marianna	Chief Operating Officer	Jul 03 '25	Sale	27.77	4,266	118,473	377,535	Jul 03 03:30 PM
GREG ZANTE	Officer	Jul 03 '25	Proposed Sale	27.76	4,266	118,428		Jul 03 01:07 PM
MARIANNA MANCINI	Officer	Jul 03 '25	Proposed Sale	27.77	4,266	118,473		Jul 03 01:05 PM
BRIAN LIAN	Officer	Jul 03 '25	Proposed Sale	27.80	26,889	747,633		Jul 03 01:01 PM
FOEHR MATTHEW W	Director	Apr 11 '25	Option Exercise	8.00	20,786	166,288	132,036	Apr 14 07:26 PM
Rouan Sarah Kathryn	Director	Mar 31 '25	Buy	24.15	1,240	29,943	1,240	Apr 02 06:29 PM
Lian Brian	President & CEO	Jan 06 '25	Sale	42.75	194,490	8,313,601	2,366,570	Jan 06 08:16 PM
Mancini Marianna	Chief Operating Officer	Jan 06 '25	Sale	42.75	54,215	2,317,599	374,134	Jan 06 08:15 PM
ZANTE GREG	Chief Financial Officer	Jan 06 '25	Sale	42.75	50,309	2,150,595	165,259	Jan 06 08:14 PM
GREG ZANTE	Officer	Jan 06 '25	Proposed Sale	42.75	50,309	2,150,594		Jan 06 05:32 PM
MARIANNA MANCINI	Officer	Jan 06 '25	Proposed Sale	42.75	54,215	2,317,599		Jan 06 05:25 PM
BRIAN LIAN	Officer	Jan 06 '25	Proposed Sale	42.75	194,490	8,313,611		Jan 06 05:16 PM
MACARTNEY LAWSON	Director	Nov 08 '24	Option Exercise	5.80	2,000	11,600	49,965	Nov 08 06:22 PM
MACARTNEY LAWSON	Director	Nov 08 '24	Sale	68.67	2,000	137,333	47,965	Nov 08 06:22 PM
LAWSON MACARTNEY	Director	Nov 08 '24	Proposed Sale	68.67	2,000	137,333		Nov 08 06:13 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '24	Option Exercise	7.49	94,001	704,282	281,053	Oct 28 09:48 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '24	Sale	76.61	131,687	10,089,164	149,366	Oct 28 09:48 PM
GREG ZANTE	Officer	Oct 28 '24	Proposed Sale	78.03	131,687	10,275,537		Oct 28 04:37 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Option Exercise	4.88	11,000	53,680	11,000	Oct 25 07:28 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Sale	80.89	11,000	889,790	0	Oct 25 07:28 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Option Exercise	4.48	16,000	71,680	25,500	Oct 25 07:27 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Sale	79.50	16,000	1,272,000	9,500	Oct 25 07:27 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Proposed Sale	80.86	11,000	889,430		Oct 25 04:10 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Proposed Sale	79.47	16,000	1,271,479		Oct 25 04:01 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Option Exercise	1.19	10,300	12,257	19,800	Sep 20 09:21 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Sale	69.50	10,300	715,850	9,500	Sep 20 09:21 PM
Lian Brian	President & CEO	Sep 20 '24	Option Exercise	7.77	166,130	1,290,830	2,521,057	Sep 20 09:20 PM
Lian Brian	President & CEO	Sep 20 '24	Sale	70.83	216,130	15,308,553	2,304,927	Sep 20 09:20 PM
Lian Brian	Officer	Sep 20 '24	Proposed Sale	18.41	216,130	3,978,372		Sep 20 04:29 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Proposed Sale	69.50	10,300	715,850		Sep 20 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VKTX

Viking Therapeutics Inc

Upgrade your FINVIZ experience